IPO Announced

Odyssey Therapeutics IPO

US$279m raised

Lodged 7 May 2026 · NASDAQ: ODTX · US$18.00 cash per share

Advisers

Odyssey Therapeutics

Issuer

Legal adviser

Lead managers

Joint lead manager
Bookrunner
TD Securities (co) (as TD Cowen)
Legal adviser
Issuer
Odyssey Therapeutics
Issuer based in
United States
Sector
Biotech
Tags
Biotech, Drug Development

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.